Impact of Adding Jones Technique to Mulligan Therapy in Patients With Cervicogenic Headache
Launched by CAIRO UNIVERSITY · Jun 24, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether adding a treatment called the Jones Technique to another therapy known as Mulligan Therapy can help people who have cervicogenic headaches. These headaches start in the neck and cause pain on one side of the head. The study aims to see if combining these treatments can reduce headache pain and improve neck movement.
People who might join the study are adults between 20 and 60 years old who have headaches caused by neck problems, especially if their pain comes from pressure on certain neck joints or neck movements. Participants should have had headaches at least once a week for three months, with a certain level of pain and some difficulty using their neck. The study will not include people with other types of headaches (like migraines), serious neck conditions, recent neck injuries or surgeries, or certain health issues like high blood pressure or bone diseases. If eligible, participants can expect to receive these therapies and have their headache pain and neck function monitored to see if the combined treatment helps. This study is not yet recruiting, so interested individuals should check back for updates.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 20 to 60 years old patient with unilaterally of the head pain
- • pain triggered by external pressure over the upper cervical joints (c1-c3)
- • pain elicited by the neck movements, and/or sustained awkward positions with reduced neck ROM
- • headache intensity pain score of at least 20mm on the Visual analogue scale (VAS)
- • headache frequency of at least once a week for at least 3 months
- • minimum neck disability index score of 10 points or greater
- Exclusion Criteria:
- • Migraine, tension- type headache, tumor, osteoporosis, fracture, rheumatoid arthritis and metabolic diseases.
- • Prolonged history of steroid use.
- • Resting blood pressure greater than 140/90 mmhg.
- • cervical spinal stenosis, diminished sensation and central nervous system involvement,
- • previous head or neck surgery or whiplash injury history within the last 6 weeks
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported